Concepedia

Publication | Open Access

Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study

DOIFull Paper Access

23

Citations

25

References

2022

Year

Ran You, Qingyu Xu, Qi Wang, Qingqiao Zhang, Wei-Zhong Zhou, Chi Cao, Xiangzhong Huang, Honghai Ji, Peng-Hua Lv, Hao Jiang,
Frontiers in Oncology

Abstract

The camrelizumab plus TACE regimen is effective and safe, indicating its potential to serve as a promising treatment choice for intermediate to advanced HCC patients.

References

YearCitations

Page 1